Search for:
Skip to content
Main Navigation
Navigate to Vor Bio Medical Affairs homepage
Our Areas of Focus
Myasthenia Gravis (MG)
Sjögren’s Disease (SjD)
Medical Congress Events
Publications
Sponsorships & Grants
Medical Information
A Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis: Trial Design Update
Geneva, Switzerland
|
2026
Focus:
Myasthenia Gravis (MG)
Location:
S04
Geneva, Switzerland
European Academy of Neurology (EAN 2026)
June 27 - 30, 2026
By selecting “Yes,” you confirm that you are a U.S.-based healthcare professional and that you are accessing this site for scientific and medical information. This site is not intended for patients, caregivers, or non-U.S. audiences.
Yes
I am a U.S.-based Medical Professional
No
I am NOT a U.S.-based Medical Professional